A novel mutant variant of the CYP2D6 gene (CYP2D617) common in a black African population: association with diminished debrisoquine hydroxylase activity-Reference-Cited by-同舟云学术

A novel mutant variant of the CYP2D6 gene (CYP2D617) common in a black African population: association with diminished debrisoquine hydroxylase activity

Published:1996-12 Issue:6 Volume:42 Page:713-719
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

MASIMIREMBWA COLLEN¹,PERSSON IRENE¹,BERTILSSON LEIF²,HASLER JULIA³,INGELMAN‐SUNDBERG MAGNUS¹

Affiliation:

1. Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S‐17177 Stockholm,

2. Department of Medical Laboratory Sciences and Technology, Huddinge University Hospital, Huddinge, Sweden,

3. Department of Biochemistry, University of Zimbabwe, Harare, Zimbabwe

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2125.1996.00489.x

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data;Clinical and Translational Science;2024-03

2. Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients;BMC Psychiatry;2024-01-10

3. Leveraging in Vitro Models for Clinically Relevant RareCYP2D6Variants in Pharmacogenomics;Drug Metabolism and Disposition;2024-01-02

4. Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry;PLOS ONE;2023-10-03

5. Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases;Journal of Personalized Medicine;2023-07-26